Cyrus Poonawalla Highlights Serum Institute's Commitment to Affordable Vaccines at ET Awards
ET Awards: Cyrus Poonawalla reflects on SII’s mission of affordable vaccines and saving lives worldwide
The Economic Times
Image: The Economic Times
Cyrus Poonawalla, chairman of Serum Institute of India (SII), emphasized the company's mission to provide affordable vaccines during his acceptance of the ET Lifetime Achievement Award. Since its inception in 1966, SII has saved over 30 million lives by supplying vaccines to more than 100 countries, with a focus on making healthcare accessible and self-reliant.
- 01Cyrus Poonawalla founded Serum Institute of India in 1966 with a mission to make healthcare affordable.
- 02SII has saved over 30 million lives by providing vaccines to more than 100 countries.
- 03The company is a leader in supplying vaccines for diseases like polio, measles, and hepatitis B.
- 04SII gained global recognition during the COVID-19 pandemic with its Covishield vaccine.
- 05Poonawalla hopes his son Adar will continue the legacy of protecting underprivileged children worldwide.
Advertisement
In-Article Ad
Cyrus Poonawalla, the chairman and managing director of Serum Institute of India (SII), received the ET Lifetime Achievement Award and reflected on the company's enduring mission to provide affordable vaccines. Since its establishment in 1966 with an initial capital of ₹5 lakh (approximately $6,000 USD), SII has prioritized making healthcare accessible and self-reliant. Poonawalla stated that the institute has saved over 30 million lives by supplying vaccines to more than 100 countries, particularly benefiting low-income nations. He highlighted the importance of scientific excellence and understanding the greatest healthcare needs. SII became widely recognized during the COVID-19 pandemic for its Covishield vaccine, which played a crucial role in controlling the virus's spread. Looking to the future, Poonawalla expressed confidence that his son, Adar Poonawalla, will continue this vital work of protecting underprivileged children globally.
Advertisement
In-Article Ad
The work of Serum Institute of India significantly improves public health by providing vaccines at low costs, especially benefiting low-income populations.
Advertisement
In-Article Ad
Reader Poll
Do you believe affordable vaccines should be a global priority?
Connecting to poll...
More about Serum Institute of India
Read the original article
Visit the source for the complete story.